SPDR Series Trust SPDR S&P Biotech ETF (XBI): Price and Financial Metrics ETF
XBI Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
Current price | $96.96 | 52-week high | $105.47 |
Prev. close | $100.01 | 52-week low | $69.32 |
Day low | $96.87 | Volume | 15,029,301 |
Day high | $100.17 | Avg. volume | 9,369,046 |
50-day MA | $99.04 | Dividend yield | 0.14% |
200-day MA | $94.90 |
XBI Stock Price Chart Interactive Chart >
SPDR Series Trust SPDR S&P Biotech ETF (XBI) ETF Bio
The investment objective of the SPDR S&P Biotech ETF is to provide investment results that correspond generally to the total return performance of the S&P Biotechnology Select Industry Index.
XBI ETF Info
Issuer | State Street Global Advisors |
Expense Ratio | 0.35% |
Underlying Index | S&P Biotechnology Select Industry Index |
Asset Class | Equity |
Sector | Health & Biotech ETFs |
Assets Under Management (AUM) | 7.88B |
Net Asset Value (NAV) | $100.02 |
Options? | Yes |
Total Holdings | 148 |
XBI Top Holdings
Symbol | Company | % of Total |
INCY | INCYTE CORP | 3.15% |
UTHR | UNITED THERAPEUTICS CORP | 2.94% |
GILD | GILEAD SCIENCES INC | 2.83% |
NTRA | NATERA INC | 2.66% |
NBIX | NEUROCRINE BIOSCIENCES INC | 2.58% |
ALNY | ALNYLAM PHARMACEUTICALS INC | 2.52% |
VRTX | VERTEX PHARMACEUTICALS INC | 2.51% |
INSM | INSMED INC | 2.34% |
SRPT | SAREPTA THERAPEUTICS INC | 2.28% |
VKTX | VIKING THERAPEUTICS INC | 2.26% |
XBI Price Returns
1-mo | -3.28% |
3-mo | -0.81% |
6-mo | 6.49% |
1-year | 38.47% |
3-year | -22.00% |
5-year | 14.81% |
YTD | 8.74% |
2023 | 7.60% |
2022 | -25.87% |
2021 | -20.45% |
2020 | 48.33% |
2019 | 32.56% |
XBI Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |